Jean Franchi
Equibles does not estimate personal net worth.
Get an email with a short summary when Disc Medicine, Inc. publishes a filing, an earnings call transcript or a press release.
Get IRON alertsAbout Jean Franchi
Jean Franchi is recorded as CFO at Disc Medicine, Inc. (IRON). The newest filing on record that lists Jean Franchi as CFO at Disc Medicine, Inc. (IRON) is dated April 28, 2026. Earlier roles on record: CFO at Replimune Group, Inc. (REPL) until June 2, 2023. Disc Medicine, Inc. reported in an 8-K filed February 7, 2024 that Jean Franchi was appointed Chief Financial Officer. Replimune Group, Inc. reported in an 8-K filed May 18, 2023 that Jean Franchi resigned as Chief Financial Officer, effective June 2, 2023. The proxy statement of Disc Medicine, Inc. reports total compensation of $4,169,143 for Jean Franchi in fiscal 2025, including a base salary of $531,000. Disclosed compensation is on record for 4 fiscal years. Disc Medicine, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Disc Medicine, Inc. includes Georges Gemayel (CEO and Board Member), Jason Meyenburg (CEO and Board Member), John Quisel (CEO and Board Member) and 7 others.
“Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the appointment of Jean Franchi as the company's Chief Financial Officer.”
“On May 18, 2023, the Company announced that Jean Franchi has resigned from her position as the Company's Chief Financial Officer, effective as of June 2, 2023 (the "Effective Date"), to pursue other opportunities.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 28, 2026
-
Start not stated–2023-06-02
Company network
Leadership on record at Disc Medicine, Inc.
- Georges Gemayel CEO, Board Member
- Jason Meyenburg CEO, Board Member
- John Quisel CEO, Board Member
- Donald Nicholson Chairman, Board Member
- Georges Gemayel, Ph.D. Chairman, Board Member
- Gregg Beloff CFO
- Jean M. Franchi CFO, Chief Accounting Officer
- Joanne Bryce, C.P.A CFO
- Jonathan Yu COO
- Dr. Scott Lauder CTO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | $531,000 | $4,169,143 |
| 2024 | Disc Medicine, Inc. (IRON) | Chief Financial Officer | $464,491 | $5,300,150 |
| 2023 | Replimune Group, Inc. (REPL) | Chief Financial Officer and Treasurer | $464,500 | $2,608,123 |
| 2020 | Replimune Group, Inc. (REPL) | Chief Financial Officer | $132,377 | $1,802,202 |